Last reviewed · How we verify
Vehicle topical ocular, eye drops
Vehicle topical ocular eye drops act as a carrier for other medications, allowing them to be delivered directly to the eye.
Vehicle topical ocular eye drops act as a carrier for other medications, allowing them to be delivered directly to the eye. Used for Treatment of dry eye disease.
At a glance
| Generic name | Vehicle topical ocular, eye drops |
|---|---|
| Also known as | Vehicle |
| Sponsor | Novaliq GmbH |
| Modality | Small molecule |
| Therapeutic area | Ophthalmology |
| Phase | Phase 3 |
Mechanism of action
Vehicle topical ocular eye drops are designed to improve the solubility and stability of other medications, enabling them to be administered in a more effective and targeted manner. This can enhance the bioavailability of the active ingredient and reduce systemic side effects.
Approved indications
- Treatment of dry eye disease
Common side effects
- Eye irritation
Key clinical trials
- AGN-193408 SR in the Treatment of Open-angle Glaucoma or Ocular Hypertension (PHASE1, PHASE2)
- A Study Evaluating the Safety and Efficacy of a Fixed-Dose Combination for Dry Eye Disease (PHASE2)
- A Study to Evaluate the Use of Topical Ocular BL1332 for the Management of Postoperative Ocular Pain Following Photorefractive Keratectomy (PHASE2)
- Efficacy of Topical Mesenchymal Stromal Cell Secretome for Ocular Surface Disease (PHASE2)
- A Study to Assess Safety, Tolerability, and Pharmacokinetics of Ascending Concentrations of Topical Ocular BL1332 in Healthy Volunteers (PHASE1)
- The Safety and Efficacy of SYD-101 in Children With Myopia (PHASE3)
- A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 1) (PHASE2, PHASE3)
- A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 2) (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Vehicle topical ocular, eye drops CI brief — competitive landscape report
- Vehicle topical ocular, eye drops updates RSS · CI watch RSS
- Novaliq GmbH portfolio CI